VERRICA PHARMACEUTICALS INC.

Profile

Company Names

VERRICA PHARMACEUTICALS INC.

Addresses

44 W. GAY ST., SUITE 400, WEST CHESTER, PA 19380

200 GARRETT STREET, SUITE S, CHARLOTTESVILLE, VA 22902

918 MCCUE AVENUE, SAN CARLOS, CA 94070

Phone Numbers

484-453-3300
434-980-8105
(510) 409-5791

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$77,451,564.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-11-25 
$50,017,383.00 
$50,017,383.00 
$0.00 
Equity 
3
2018-02-20 
$19,999,995.00 
$21,000,000.00 
$1,000,005.00 
Equity 
2
2017-12-15 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
1
2015-12-02 
$2,434,186.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOSEPH 
 
BONACCORSO 
EXECUTIVE OFFICER
VERRICA PHARMACEUTICALS INC.
ANTHONY 
 
CAVALLO 
EXECUTIVE OFFICER
VERRICA PHARMACEUTICALS INC.
GAVIN 
 
CORCORAN 
DIRECTOR
VERRICA PHARMACEUTICALS INC.
MATTHEW 
 
DAVIDSON 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
VERRICA PHARMACEUTICALS INC.   |  HALCYON HOLDING CORP   |  AZORA THERAPEUTICS, INC.
LAWRENCE 
 
EICHENFIELD 
DIRECTOR
FORTE BIOSCIENCES, INC.   |  FORTE BIOSCIENCES, INC.   |  VERRICA PHARMACEUTICALS INC.
JOHN 
 
KIRBY 
EXECUTIVE OFFICER
ALCO MANUFACTURING HOLDING CORP   |  MERCER SONOCO INVESTMENT FUND, A SERIES OF MERCER GROUP TRUST   |  MERCER SUNOCO INVESTMENT FUND, A PORTFOLIO OF MERCER GROUP TRUST   |  VERRICA PHARMACEUTICALS INC.
PAUL 
 
MANNING 
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
GEN9, INC.   |  ENZYMATICS INC   |  AVEXIS, INC.   |  VERRICA PHARMACEUTICALS INC.   |  ARCHERDX, INC.   |  ADVANTAGENE, INC.   |  TOLERION, INC.   |  BLUE MARLIN THERAPEUTICS, INC.
PAUL 
B. 
MANNING 
DIRECTOR
DOVA PHARMACEUTICALS, INC.   |  XALUD THERAPEUTICS, INC.   |  ARCHERDX, INC.   |  TAYSHA GENE THERAPIES, INC.   |  LIQUIDIA CORP   |  VERRICA PHARMACEUTICALS INC.
DIEM 
 
NGUYEN 
DIRECTOR
EXTEND DEVICE CORP   |  XALUD THERAPEUTICS, INC.   |  VITARA BIOMEDICAL, INC.   |  VERRICA PHARMACEUTICALS INC.
GLENN 
 
OCLASSEN 
DIRECTOR, PROMOTER
VERRICA PHARMACEUTICALS INC.
MARK 
 
PRYGOCKI 
DIRECTOR
ILLUSTRIS PHARMACEUTICALS INC.   |  VERRICA PHARMACEUTICALS INC.
JAMES 
C. 
REEBALS 
EXECUTIVE OFFICER, PROMOTER
DOVA PHARMACEUTICALS, INC.   |  VERRICA PHARMACEUTICALS INC.
JAYSON 
 
RIEGER 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
INTREXON CORP   |  VERRICA PHARMACEUTICALS INC.   |  XALUD THERAPEUTICS, INC.
NOAH 
 
ROSENBERG 
EXECUTIVE OFFICER
FLAT WORLD KNOWLEDGE INC   |  BRIGHTFIELD HOLDINGS, LLC   |  BRIGHTFIELD HOLDINGS, INC.   |  VERRICA PHARMACEUTICALS INC.
SEAN 
 
STALFORT 
DIRECTOR, PROMOTER
VERRICA PHARMACEUTICALS INC.   |  ADVANTAGENE, INC.   |  XALUD THERAPEUTICS, INC.   |  TOLERION, INC.   |  SALIOGEN THERAPEUTICS, INC.   |  TAYSHA GENE THERAPIES, INC.   |  BLUE MARLIN THERAPEUTICS, INC.
TED 
 
WHITE 
EXECUTIVE OFFICER
VERRICA PHARMACEUTICALS INC.
DAVID 
 
ZAWITZ 
EXECUTIVE OFFICER
VERRICA PHARMACEUTICALS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-12-10
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-11-25 
2018-02-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-20 
2017-12-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-15 
2015-12-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
TD SECURITIES (USA) LLC
18476
NONE
NONE
IMS HEALTH CAPITAL, INC.
150156